These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8362410)
1. A human monoclonal antibody that detects HLA-A1, A23 and A24 antigens. Kubo K; Tachino J; Yamaguchi H; Kurachi T; Naoe T; Ohno R; Ueda K Tissue Antigens; 1993 Apr; 41(4):186-9. PubMed ID: 8362410 [TBL] [Abstract][Full Text] [Related]
2. A new murine lymphocytotoxic monoclonal antibody recognizing HLA-A2, -A28 and -A9. Mizuno S; Yako F; Ohta H; Kato T; Wada K; Uchigiri C; Furuta M; Ohya K; Kurachi T; Murase T; Kamiya T; Ozawa K Tissue Antigens; 1996 Sep; 48(3):224-7. PubMed ID: 8896185 [TBL] [Abstract][Full Text] [Related]
3. Nucleotide sequences of the variable regions of a human monoclonal antibody against HLA-A1, A23, and A24. Ichihashi T; Kubo K; Naoe T; Ohno R Tissue Antigens; 1993 May; 41(5):249-54. PubMed ID: 7694391 [TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against HLA-A11 and A24. Foung SK; Taidi B; Ness D; Grumet FC Hum Immunol; 1986 Mar; 15(3):316-9. PubMed ID: 2420768 [TBL] [Abstract][Full Text] [Related]
5. Screening a hybridoma producing a specific monoclonal antibody to HLA-A24+Bw4 antigen by cytotoxicity inhibition assay. Hiroishi S; Kaneko T; Arita J Tissue Antigens; 1987 Feb; 29(2):120-2. PubMed ID: 3299870 [TBL] [Abstract][Full Text] [Related]
6. HLA-A9 antibodies and epitopes. Fussell H; Thomas M; Street J; Darke C Tissue Antigens; 1996 Apr; 47(4):307-12. PubMed ID: 8773320 [TBL] [Abstract][Full Text] [Related]
7. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody. Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447 [TBL] [Abstract][Full Text] [Related]
8. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules. Pettersen RD; Hestdal K; Lee N; Geraghty DE; Valø ET; Lie SO; Gaudernack G Tissue Antigens; 1995 Mar; 45(3):203-12. PubMed ID: 7539160 [TBL] [Abstract][Full Text] [Related]
9. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
10. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Wang X; Liang B; Rebmann V; Lu J; Celis E; Kageshita T; Grosse-Wilde H; Ferrone S Tissue Antigens; 2003 Aug; 62(2):139-48. PubMed ID: 12889994 [TBL] [Abstract][Full Text] [Related]
11. Production and applications of new monoclonal antibodies against human lymphocyte antigen-A and -B antigens. Harpprecht J; Westphal E; Müller-Ruchholtz W Diagn Clin Immunol; 1988; 5(6):388-92. PubMed ID: 3219787 [TBL] [Abstract][Full Text] [Related]
12. A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA-A2 subtypes and HLA-A28. Mulder A; Kardol M; Blom J; Jolley WB; Melief CJ; Bruning H Tissue Antigens; 1993 Jul; 42(1):27-34. PubMed ID: 7504327 [TBL] [Abstract][Full Text] [Related]
13. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724 [TBL] [Abstract][Full Text] [Related]
14. A cytotoxic human-human hybridoma antibody (TrC7) specific for HLA-A29. Kolstad A; Bratlie A; Hannestad K Tissue Antigens; 1989 May; 33(5):542-5. PubMed ID: 2552611 [TBL] [Abstract][Full Text] [Related]
15. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires. Sidney J; Southwood S; Sette A Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466 [TBL] [Abstract][Full Text] [Related]
16. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493 [TBL] [Abstract][Full Text] [Related]
17. Distribution of the HLA-A9 antigen family (A23, A24 and A2403). Thomas M; Street J; Fussell H; Guttridge M; Darke C Tissue Antigens; 1996 Nov; 48(5):586-8. PubMed ID: 8988542 [TBL] [Abstract][Full Text] [Related]
18. Recognition of HLA-A1 by murine monoclonal antibodies. Carrel S; Salvi S; Hartmann F; Rimoldi D Tissue Antigens; 1994 Feb; 43(2):110-5. PubMed ID: 8016837 [TBL] [Abstract][Full Text] [Related]
19. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes. Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111 [TBL] [Abstract][Full Text] [Related]
20. Characterization of four murine monoclonal antibodies recognizing respectively HLA-A2 plus Aw69, HLA-B13, HLA-Bw4 and HLA-A28. Xu X; Wang C; Li Q; D'Alfonso S; Pozzi C; Richiardi P Tissue Antigens; 1990 Feb; 35(2):101-2. PubMed ID: 2343451 [No Abstract] [Full Text] [Related] [Next] [New Search]